Flotek Industries Inc. (FTK) is expected to report $0.1 for Q4 2024
LEG Immobilien SE Registered Shares (LEGIF) is expected to report for quarter end 2024-12-31
Nemaura Medical Inc. (NMRD) is expected to report for quarter end 2024-12-31
Rand Capital Corporation (RAND) is expected to report for quarter end 2024-12-31
Investcorp Credit Management BDC Inc. (ICMB) is expected to report for Q2 2025
Sonendo Inc. (SONX) is expected to report for Q4 2024
Natura &Co Holding S.A. (NTCOY) is expected to report for Q4 2024
Morgan Advanced Materials Plc (MCRUF) is expected to report for quarter end 2024-12-31
PaxMedica Inc. (PXMD) is expected to report for quarter end 2024-12-31
Atlanticus Holdings Corporation (ATLC) is expected to report $1.21 for Q4 2024
Fuchs SE ADR (Representing Pref. Shares) (FUPBY) is expected to report for Q4 2024
Redwire Corporation (RDW) is expected to report $-0.18 for Q4 2024
Parkson Retail Group Ltd. ADR (PKSGY) is expected to report for quarter end 2024-12-31
Empresa Distribuidora Y Comercializadora Norte S.A. (Edenor) American Depositary Shares (EDN) is expected to report for Q4 2024
Asana Inc. Class A (ASAN) is expected to report $-0.25 for Q4 2025
Limbach Holdings Inc. (LMB) is expected to report $0.78 for Q4 2024
KalVista Pharmaceuticals Inc. (KALV) is expected to report $-0.89 for Q3 2025
Canterbury Park Holding Corporation (CPHC) is expected to report for quarter end 2024-12-31
Astria Therapeutics Inc. (ATXS) is expected to report $-0.45 for Q4 2024
Genie Energy Ltd. Class B Stock (GNE) is expected to report for quarter end 2024-12-31
Fennec Pharmaceuticals Inc. (FENC) is expected to report $0.56 for Q4 2024
Auna SA Class A (AUNA) is expected to report $0.15 for Q4 2024
NET Power Inc. Class A (NPWR) is expected to report for Q4 2024
Coherus BioSciences Inc. (CHRS) is expected to report $-0.29 for Q4 2024
The ONE Group Hospitality Inc. (STKS) is expected to report $0.12 for Q4 2024
Golden Grail Technology Corp (GOGY) is expected to report for quarter end 2024-12-31
The Beachbody Company Inc. Class A (BODI) is expected to report $-2.88 for Q4 2024
Verify Smart Corp (VSMR) is expected to report for quarter end 2024-12-31
Scilex Holding Company (SCLX) is expected to report $-0.09 for Q4 2024
Assertio Holdings Inc. (ASRT) is expected to report $-0.04 for Q4 2024
Toro Corp. (TORO) is expected to report for Q4 2024
Mission Produce Inc. (AVO) is expected to report $-0.01 for Q1 2025
Franco-Nevada Corporation (FNV) is expected to report $0.89 for Q4 2024
Hesai Group (HSAI) is expected to report for Q4 2024
StandardAero Inc. (SARO) is expected to report $0.16 for Q4 2024
Central Puerto S.A. American Depositary Shares (each represents ten) (CEPU) is expected to report for Q4 2024
Belite Bio Inc (BLTE) is expected to report $-0.3 for Q4 2024
BioNTech SE (BNTX) is expected to report $0.61 for Q4 2024
Brainchip Holdings Ltd (BRCHF) is expected to report for quarter end 2024-12-31
Paymentus Holdings Inc. Class A (PAY) is expected to report $0.09 for Q4 2024
Cara Therapeutics Inc. (CARA) is expected to report for Q4 2024
Telos Corporation (TLS) is expected to report $-0.21 for Q4 2024
DarioHealth Corp. (DRIO) is expected to report $-0.31 for Q4 2024
Yalla Group Limited American Depositary Shares each representing one Class A (YALA) is expected to report for quarter end 2024-12-31
PLAYSTUDIOS Inc. (MYPS) is expected to report $-0.14 for Q4 2024
Olema Pharmaceuticals Inc. (OLMA) is expected to report $-0.63 for Q4 2024
Vail Resorts Inc. (MTN) is expected to report $6.29 for Q2 2025
Lexeo Therapeutics, Inc. (LXEO) is expected to report $-0.81 for Q4 2024
Aqua Power Systems Inc (APSI) is expected to report for Q3 2025
ContextLogic Inc. (LOGC) is expected to report for quarter end 2024-12-31
Optical Cable Corporation (OCC) is expected to report for Q1 2025
NCS Multistage Holdings Inc. (NCSM) is expected to report for quarter end 2024-12-31
Quanex Building Products Corporation (NX) is expected to report $-0.06 for Q1 2025
Commercial Vehicle Group Inc. (CVGI) is expected to report $-0.07 for Q4 2024
Greenlight Reinsurance Ltd. (GLRE) is expected to report for quarter end 2024-12-31
Beasley Broadcast Group Inc. (BBGI) is expected to report for Q4 2024
Manhattan Bridge Capital Inc (LOAN) is expected to report for quarter end 2024-12-31
Ramaco Resources Inc. Class B Common Stock (METCB) is expected to report for Q4 2024
Glanbia Plc ADR (GLAPY) is expected to report for quarter end 2024-12-31
GlobeStar Therapeutics Corp (GSTC) is expected to report for quarter end 2024-12-31
Domino`s Pizza Group Plc ADR (DPUKY) is expected to report for Q4 2024
CURO Group Holdings Corp. (CUROQ) is expected to report for quarter end 2024-12-31
Neurogene Inc. (NGNE) is expected to report $-1.1 for Q4 2024
HighPeak Energy Inc. (HPK) is expected to report $0.13 for Q4 2024
Viemed Healthcare Inc. (VMD) is expected to report for quarter end 2024-12-31
Mitsubishi Electric Corporation ADR (MIELY) is expected to report for Q3 2025
LifeMD Inc. (LFMD) is expected to report $-0.05 for Q4 2024
Akoya BioSciences Inc. (AKYA) is expected to report $-0.15 for Q4 2024
Aligos Therapeutics Inc. (ALGS) is expected to report $-1.91 for Q4 2024
Delta Apparel Inc. (DLAPQ) is expected to report for quarter end 2024-12-31
TruBridge Inc. (TBRG) is expected to report $0.5 for Q4 2024
BBB Foods Inc. Class A (TBBB) is expected to report $0.02 for Q4 2024
Gaia Inc. (GAIA) is expected to report $-0.03 for Q4 2024
System1 Inc. Class A (SST) is expected to report for quarter end 2024-12-31
Willis Lease Finance Corporation (WLFC) is expected to report for quarter end 2024-12-31
Caribou Biosciences Inc. (CRBU) is expected to report $-0.4 for Q4 2024
Mustang Bio Inc. (MBIO) is expected to report $-5.5 for Q4 2024
Great Elm Capital Corp. (GECC) is expected to report $0.34 for Q4 2024
Cadrenal Therapeutics Inc. (CVKD) is expected to report $-1.71 for Q4 2024
Oracle Corporation (ORCL) is expected to report $1.18 for Q3 2025
Douglas Elliman Inc. (DOUG) is expected to report for Q4 2024
Enghouse Systems Ltd (EGHSF) is expected to report for Q1 2025
Nektar Therapeutics (NKTR) is expected to report $-0.13 for Q4 2024
UroGen Pharma Ltd. (URGN) is expected to report $-0.74 for Q4 2024
USD Partners LP representing limited partner interest (USDP) is expected to report for quarter end 2024-12-31
